FindMyKOL

Claudia Panzer, MD

Basic profile

Rose Medical Center

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionDenver, CO · WestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLFindMyKOL type: RegionalLatest publication2009Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Claudia Panzer is an Endocrinology/Metabolic physician affiliated with Rose Medical Center. OpenAlex indexes 17 publications with 463 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
17publications

Publications indexed by OpenAlex. Counts exclude supporting files.

463citations

Citations across these publications.

6h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
17companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Alexion Pharmaceuticals, Inc.
    Program year20251 payment
    $135
  • Medtronic, Inc.
    Program year20251 payment
    $102
  • Amneal Pharmaceuticals LLC
    Program year20254 payments
    $70
All 28 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    46.1%
    GLP-1 receptor agonist20.1%
    Ozempic53%Mounjaro40%Trulicity7%
    Part D<11 patients
    Biguanide (metformin)10.9%
    Metformin Hcl Er91%Metformin Hcl9%
    Part D<11 patients

    + 5 more classes in this area

  • Hormonal (systemic)

    28.3%
    l-Thyroxine24.9%
    Levothyroxine Sodium56%Synthroid29%Unithroid15%
    Part D≥58 patients
    l-Triiodothyronine1.5%
    Liothyronine Sodium100%
    Part D<11 patients

    + 2 more classes in this area

  • Cardiovascular

    19.3%
    Statin9%
    Atorvastatin Calcium63%Rosuvastatin Calcium19%Pravastatin Sodium9%Simvastatin9%
    Part D<11 patients
    ACE inhibitor3%
    Lisinopril65%Ramipril35%
    Part D<11 patients

    + 5 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”